Glenmark Pharmaceuticals Inc., USA is voluntarily recalling several dozen lots of Mometasone Furoate Cream USP, 0.1%, which is used to treat skin conditions. The recall was initiated after the company received consumer complaints that the cream had a gritty texture rather than being smooth. This grit indicates a manufacturing deviation that could affect the quality and application of the medication. The products were distributed nationwide in 15-gram and 45-gram tubes.
The gritty texture of the cream represents a deviation from Good Manufacturing Practices (GMP) and may cause skin irritation or reduced effectiveness of the medication when applied to sensitive or inflamed skin areas.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES ยท Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.